Cognitive & Nootropic

Pinealon

Pinealon is a brain-targeted member of the same Khavinson bioregulator family behind Epitalon and Cartalax — short synthetic peptides proposed to influence gene expression directly, rather than acting through a conventional receptor pathway.

Not currently stocked by KYIN Peptides, but available to order — see availability below.

What Is Pinealon?

Pinealon is a synthetic tripeptide (Glu-Asp-Arg) from the same Khavinson bioregulator family as Cartalax and Epitalon, but targeted at brain tissue rather than cartilage or the pineal gland's telomerase pathway. It is proposed to cross the blood-brain barrier via the PEPT2 peptide transporter and bind DNA regulatory regions in cortical cells, modulating gene expression linked to oxidative stress and cognitive aging — a mechanism, like Cartalax's, that rests on the same disputed direct peptide-DNA-binding hypothesis rather than a conventional receptor pathway.

Research Focus

Pinealon's brain-bioregulator research sits alongside the anxiolytic research behind Selank and neuroprotective research behind Semax in KYIN's Cognitive & Nootropic category, though it approaches cognitive research from the same gene-expression-modulation angle as its Khavinson-lineage siblings rather than a classical neuropeptide mechanism. See our Cognitive & Nootropic research overview for how it fits alongside KYIN's stocked cognitive peptides, or how DSIP compares as another non-stocked compound in this category.

Clinical & Preclinical Trial Data

All published evidence is preclinical, from cell-culture and rodent work concentrated within a single research group. Studies report Pinealon improved learning and memory performance in aged rats, reduced reactive oxygen species accumulation and lipid peroxidation in neuronal tissue, and preserved mitochondrial membrane potential in neuronal cultures exposed to oxidative stress, hypoxia, and ischemia. No human clinical trial has been conducted, no dose has been established for human use, and it has not been evaluated by the FDA.

Availability

Pinealon is not part of KYIN Peptides' standard catalogue, but it is available to order — contact us directly and we'll source it for you.

⚠

Research Use Only Notice This page provides general research and educational context about Pinealon only, and does not constitute medical, dosing, or human-use advice. It is not a claim about current regulatory approval, safety, or legal status in any market. Any Pinealon sourced through KYIN Peptides is sold strictly for laboratory research use by qualified professionals — not for human or animal use, and not intended for diagnostic, therapeutic, or consumption purposes.

FAQ

Pinealon questions

What is Pinealon?

Pinealon is a synthetic tripeptide (Glu-Asp-Arg) from the same Khavinson bioregulator family as Cartalax and Epitalon, but targeted at brain tissue. It is proposed to cross the blood-brain barrier via the PEPT2 peptide transporter and bind DNA regulatory regions in cortical cells, modulating gene expression linked to oxidative stress and cognitive aging.

How strong is the evidence behind Pinealon?

All published evidence is preclinical, from cell-culture and rodent work concentrated within a single research group. No human clinical trial has been conducted, no dose has been established for human use, and it has not been evaluated by the FDA.

Does KYIN Peptides sell Pinealon?

Not as part of our standard catalogue, but yes — it's available to order. Contact us directly and we'll source it for you.

Interested in sourcing Pinealon?

Contact to Order Cognitive & Nootropic Overview